UNITED THERAPEUTICS CORP (UTHR)

US91307C1027 - Common Stock

233.85  -2.1 (-0.89%)

After market: 233.85 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
1.686B
13.63%		1.936B
14.88%		2.328B
20.20%		2.754B
18.32%
EBITDA
YoY % growth
738.4M
14.75%		1.042B
41.14%		1.242B
19.14%		1.432B
15.33%
EBIT
YoY % growth
688.5M
15.99%		990.9M
43.92%		1.189B
19.94%		1.464B
23.18%
Operating Margin
40.85%51.17%51.06%53.16%
EPS
YoY % growth
10.03
-13.39%		15.02
49.75%		19.84
32.09%		24.52
23.58%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		5.76
18.61%
Revenue
Q2Q % growth		632.53M
24.78%
EBITDA
Q2Q % growth		345.57MN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		339.97M
19.54%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 4.36
63.30%		4.270.092.12%
Q3 2023
Q2Q % growth		 5.38
9.57%		5.140.244.59%
Q2 2023
Q2Q % growth		 5.24
117.43%		4.600.6414.02%
Q1 2023
Q2Q % growth		 4.86
-3.38%		4.620.245.31%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 614.7M
25.07%		587.39M27.31M4.65%
Q3 2023
Q2Q % growth		 609.4M
18.10%		598.84M10.56M1.76%
Q2 2023
Q2Q % growth		 596.5M
27.76%		534.65M61.85M11.57%
Q1 2023
Q2Q % growth		 506.9M
9.74%		524.66M-17.76M-3.39%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.04% 1.42% 0.74% 8.93%
Revenue0.06% 1.6% -0.04% 7.7%